Bayer Shares Slide as $7.25B Roundup Settlement Faces Investor Doubts
Bayer shares fell sharply Wednesday, erasing prior gains, as investors questioned whether its proposed $7.25 billion Roundup settlement signals a decisive legal turnaround. The German pharmaceutical and crop science group announced an
